Obagi Medical Products, Inc. (NASDAQ:OMPI)

CAPS Rating: 3 out of 5

A pharmaceutical company focused on the aesthetic and skin health markets. The Company develops and commercializes prescription-based, topical skin health systems.

Recs

0
Player Avatar fallond (< 20) Submitted: 1/23/2013 6:45:39 AM : Outperform Start Price: $13.82 OMPI Score: +64.21

Featured: http://beta.fool.com/fallond/2012/06/21/diverse-speculative-buying-drives-rally/5961/

Still recovering from the summer sell off, but the undercurrent has favored accumulation over selling.

Featured Broker Partners


Advertisement